You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
The New England journal of medicine·2018
Same author
Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.
Cell medicine·2016
Same author
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
European journal of nuclear medicine and molecular imaging·2015
Same author
[Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?].
Bulletin du cancer·2014
Same author
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.
Gastroenterology·2013
Same author
Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.
JIMD reports·2013
Same journal
Retraction notice to "Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population" [J Hepatol 58 (2013) 271-277].
Journal of hepatology·2026
Same journal
Optimising the screening strategy for early-stage hepatocellular carcinoma.
Journal of hepatology·2026
Same journal
Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].
Journal of hepatology·2026
Same journal
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.
Journal of hepatology·2026
Same journal
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.
Journal of hepatology·2026
Same journal
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.
Journal of hepatology·2026


